Schnack C - Search Results

1

Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.

Ludvik B, Lell B, Hartter E, Schnack C, Prager R. Ludvik B, et al. Among authors: schnack c. Diabetes. 1991 Dec;40(12):1615-9. doi: 10.2337/diab.40.12.1615. Diabetes. 1991. PMID: 1756902

2

Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.

Schnack C, Prager RJ, Winkler J, Klauser RM, Schneider BG, Schernthaner G. Schnack C, et al. Diabetes Care. 1989 Sep;12(8):537-43. doi: 10.2337/diacare.12.8.537. Diabetes Care. 1989. PMID: 2673693 Clinical Trial.

3

Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus.

Klauser R, Prager R, Gaube S, Gisinger C, Schnack C, Küenburg E, Schernthaner G. Klauser R, et al. Among authors: schnack c. Hypertension. 1991 Jan;17(1):15-21. doi: 10.1161/01.hyp.17.1.15. Hypertension. 1991. PMID: 1824760 Clinical Trial.

4

Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular disease.

Knöbl P, Pietschmann P, Schnack C, Prager R, Schernthaner G. Knöbl P, et al. Among authors: schnack c. Wien Klin Wochenschr. 1994;106(23):728-32. Wien Klin Wochenschr. 1994. PMID: 7856176

5

Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients.

Knöbl P, Schernthaner G, Schnack C, Pietschmann P, Proidl S, Prager R, Vukovich T. Knöbl P, et al. Among authors: schnack c. Thromb Haemost. 1994 Jun;71(6):692-7. Thromb Haemost. 1994. PMID: 7974333

6

Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus.

Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G, et al. Griesmacher A, et al. Among authors: schnack c. Am J Med. 1995 May;98(5):469-75. doi: 10.1016/s0002-9343(99)80347-7. Am J Med. 1995. PMID: 7733126

7

Apolipoprotein (a) levels and atherogenic lipid fractions in relation to the degree of urinary albumin excretion in type 2 diabetes mellitus.

Schnack C, Pietschmann P, Knöbl P, Schuller E, Prager R, Schernthaner G. Schnack C, et al. Nephron. 1994;66(3):273-7. doi: 10.1159/000187822. Nephron. 1994. PMID: 8190178

8

Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.

Knöbl P, Schernthaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, Müller M. Knöbl P, et al. Among authors: schnack c. Diabetologia. 1993 Oct;36(10):1045-50. doi: 10.1007/BF02374497. Diabetologia. 1993. PMID: 8243853

9

Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.

Capek M, Schnack C, Ludvik B, Kautzky-Willer A, Banyai M, Prager R. Capek M, et al. Among authors: schnack c. Clin Investig. 1994 Dec;72(12):961-6. doi: 10.1007/BF00577736. Clin Investig. 1994. PMID: 7711427 Clinical Trial.

10

Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria.

Schnack C, Capek M, Banyai M, Kautzky-Willer A, Prager R, Schernthaner G. Schnack C, et al. Acta Diabetol. 1994 Apr;31(1):14-8. doi: 10.1007/BF00580754. Acta Diabetol. 1994. PMID: 8043891 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters